Cargando…
Gabapentin-related suicide: Myth or fact?
BACKGROUND: The opioid epidemic in America is real and is estimated to be the number one cause of death in adults under 50 years of age. Finding alternative analgesic medications is part of the effort to decrease the prescription of narcotics, with gabapentin being at the top of the list. CASE DESCR...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213802/ https://www.ncbi.nlm.nih.gov/pubmed/30488008 http://dx.doi.org/10.4103/sni.sni_420_17 |
_version_ | 1783367857692737536 |
---|---|
author | Ghaly, Ramsis F. Plesca, Ana Rana, Shalini Candido, Kenneth D. Knezevic, Nebojsa Nick |
author_facet | Ghaly, Ramsis F. Plesca, Ana Rana, Shalini Candido, Kenneth D. Knezevic, Nebojsa Nick |
author_sort | Ghaly, Ramsis F. |
collection | PubMed |
description | BACKGROUND: The opioid epidemic in America is real and is estimated to be the number one cause of death in adults under 50 years of age. Finding alternative analgesic medications is part of the effort to decrease the prescription of narcotics, with gabapentin being at the top of the list. CASE DESCRIPTION: In the present case, we discuss the side-effects of gabapentin, used as part of the multimodal treatment approach of painful spinal degenerative disease. The patient stated that he had noticed personality changes after gabapentin was initiated, and that he had become more depressed, frustrated, and aggressive. His uncontrolled pain and acute mood changes led him to attempt suicide by hanging himself. Gabapentin was discontinued and the patient's suicidal ideation completely subsided. CONCLUSION: It is imperative to screen, identify, and appropriately manage patients with underlying psychiatric disorders prior to initiating pain management with gabapentin. Therefore, it is crucial to raise awareness of gabapentin as a potential cause of depression, aggressive behavior, and suicidal ideation. |
format | Online Article Text |
id | pubmed-6213802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-62138022018-11-28 Gabapentin-related suicide: Myth or fact? Ghaly, Ramsis F. Plesca, Ana Rana, Shalini Candido, Kenneth D. Knezevic, Nebojsa Nick Surg Neurol Int Pain: Case Report BACKGROUND: The opioid epidemic in America is real and is estimated to be the number one cause of death in adults under 50 years of age. Finding alternative analgesic medications is part of the effort to decrease the prescription of narcotics, with gabapentin being at the top of the list. CASE DESCRIPTION: In the present case, we discuss the side-effects of gabapentin, used as part of the multimodal treatment approach of painful spinal degenerative disease. The patient stated that he had noticed personality changes after gabapentin was initiated, and that he had become more depressed, frustrated, and aggressive. His uncontrolled pain and acute mood changes led him to attempt suicide by hanging himself. Gabapentin was discontinued and the patient's suicidal ideation completely subsided. CONCLUSION: It is imperative to screen, identify, and appropriately manage patients with underlying psychiatric disorders prior to initiating pain management with gabapentin. Therefore, it is crucial to raise awareness of gabapentin as a potential cause of depression, aggressive behavior, and suicidal ideation. Medknow Publications & Media Pvt Ltd 2018-10-23 /pmc/articles/PMC6213802/ /pubmed/30488008 http://dx.doi.org/10.4103/sni.sni_420_17 Text en Copyright: © 2018 Surgical Neurology International http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Pain: Case Report Ghaly, Ramsis F. Plesca, Ana Rana, Shalini Candido, Kenneth D. Knezevic, Nebojsa Nick Gabapentin-related suicide: Myth or fact? |
title | Gabapentin-related suicide: Myth or fact? |
title_full | Gabapentin-related suicide: Myth or fact? |
title_fullStr | Gabapentin-related suicide: Myth or fact? |
title_full_unstemmed | Gabapentin-related suicide: Myth or fact? |
title_short | Gabapentin-related suicide: Myth or fact? |
title_sort | gabapentin-related suicide: myth or fact? |
topic | Pain: Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213802/ https://www.ncbi.nlm.nih.gov/pubmed/30488008 http://dx.doi.org/10.4103/sni.sni_420_17 |
work_keys_str_mv | AT ghalyramsisf gabapentinrelatedsuicidemythorfact AT plescaana gabapentinrelatedsuicidemythorfact AT ranashalini gabapentinrelatedsuicidemythorfact AT candidokennethd gabapentinrelatedsuicidemythorfact AT knezevicnebojsanick gabapentinrelatedsuicidemythorfact |